Eplerenone Tablet, Coated
Product Images NDC 71335-2355

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 71335-2355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eplerenone 01)

Chemical structure of eplerenone, the active ingredient in the drug. The image shows the molecular framework with rings, oxygen atoms, and functional groups characteristic of eplerenone's steroidal framework.*

FDA Label Image

Figure 1 (Eplerenone 02)

A line graph showing cumulative incidence percentages over months since randomization comparing Eplerenone and placebo groups. The graph illustrates a lower cumulative incidence for Eplerenone compared to placebo over 27 months, with risk ratio and p-value statistics indicated. Below the graph, a table lists the number of patients at risk in each group at various time points.*

FDA Label Image

Figure 2 (Eplerenone 03)

A forest plot titled 'Hazard Ratios of All-Cause Mortality by Subgroups' showing hazard ratios with 95% confidence intervals comparing Eplerenone to placebo across multiple subgroups by age, gender, race, diabetes status, hypertension history, Killip class, creatinine clearance, and baseline use of beta blockers, ACE inhibitors, digoxin, and diuretics. The x-axis ranges from 0.0 to 2.0 with markers indicating risk favoring Eplerenone or placebo, and columns list total number of events and patients per subgroup.*

FDA Label Image

Figure 3 (Eplerenone 04)

A scatter plot showing the reduction in systolic blood pressure (SBP) in mm Hg on the vertical axis against daily Eplerenone dosage in mg/day on the horizontal axis. Data points represent results from three studies at various dosages ranging from 0 to 200 mg/day, with a legend distinguishing the studies by different markers. The plot illustrates the relationship between Eplerenone dose and SBP reduction.*

FDA Label Image

Figure 4 (Eplerenone 05)

A scatter plot showing the reduction in diastolic blood pressure (DBP) in mm Hg versus the daily dosage of Eplerenone (mg/day). Data points representing three different studies are differentiated by symbols: diamond for Study 1 QD, circle for Study 2 QD, and square for Study 2 BID. The reduction in DBP ranges from 0 to approximately 10 mm Hg across doses up to 200 mg/day.*

FDA Label Image

Label (Lbl713352355)

Label for Eplerenone Tablets, 25 mg oral film-coated tablets. The label shows the NDC 71335-2355-1 and indicates a quantity of 90 tablets. The product is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Bluepharma Indústria Farmacêutica, S.A. S. Storage instructions and a pharmacist dispensing link are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.